Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm
Public ClinicalTrials.gov record NCT03440112. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Modulation of GABA-A Receptors and Axial Motor Impairments in Parkinson
Study identification
- NCT ID
- NCT03440112
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Nicolaas Bohnen, MD, PhD
- Other
- Enrollment
- 34 participants
Conditions and interventions
Conditions
Interventions
- Clarithromycin (Not used as of 4/2020) Drug
- Placebo (Not used as of 4/2020) Drug
- Transdermal flumazenil (Added 4/2020) Drug
- Placebo (Added 4/2020) Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 28, 2018
- Primary completion
- Dec 7, 2021
- Completion
- Dec 7, 2021
- Last update posted
- Jan 9, 2023
2018 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Michigan Health System Functional Neuroimaging, Cognitive and Mobility Laboratory | Ann Arbor | Michigan | 48106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03440112, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 9, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03440112 live on ClinicalTrials.gov.